Adamantinoma

At Dana-Farber/Children’s Hospital Cancer Center, our care is informed by our research. 

We are world leaders in opening new avenues of "translational research," bringing laboratory advances to the bedside and doctor's office as quickly as possible. All of our senior medical staff members of the Bone and Soft Tissue Tumors Program participate in clinical research activities.

Our program director, Carlos Rodriguez-Galindo, MD, is also the co-director of our new Clinical and Translational Investigation Program, which aims to dramatically improve translational research in pediatric hematology and oncology.

In addition to a variety of clinical trials, our researchers also conduct extensive laboratory research to identify new treatments and improve therapies for bone and soft tissue tumors.

Read all about our innovative approach.